Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

447
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
447
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

584
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
584
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morpho-anatomical and biochemical plasticity of chia (Salvia hispanica L.) microgreens following heavy-ion seed irradiation.

Plant physiology and biochemistry : PPB·2026
Same author

The future is not always uniform: rethinking radiotherapy through spatial fractionation.

Nature reviews. Clinical oncology·2026
Same author

Lung ion-fluoroscopy Guided Hadron therapy: LIGHT concept and proof-of-principle.

Physics in medicine and biology·2026
Same author

Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomes.

Journal of applied clinical medical physics·2026
Same author

Will upright radiotherapy become a new standard? STAND: Perspectives and acceptability from the global radiotherapy community.

Technical innovations & patient support in radiation oncology·2026
Same author

Micro CT calibration accuracy for pre-clinical studies in ion therapy.

Physics in medicine and biology·2026
Same journal

From quarks and gluons to baryon form factors.

Progress in particle and nuclear physics·2016
See all related articles

Related Experiment Video

Updated: Jul 29, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

Emerging technologies for cancer therapy using accelerated particles.

Christian Graeff1,2, Lennart Volz1, Marco Durante1,2,3

  • 1GSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Planckstraße 1, 64291 Darmstadt, Germany.

Progress in Particle and Nuclear Physics
|May 19, 2023
PubMed
Summary
This summary is machine-generated.

Particle therapy, using accelerated charged particles, offers a less toxic and more effective cancer treatment than X-rays. Innovations are needed to make this advanced radiotherapy cheaper, faster, and more conformal for wider patient use.

Keywords:
FLASHGantryMedical acceleratorsMoving targetsParticle therapyRadioactive ions

More Related Videos

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Related Experiment Videos

Last Updated: Jul 29, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Area of Science:

  • Biomedical applications of nuclear physics
  • Radiation oncology
  • Medical physics

Background:

  • Cancer therapy with accelerated charged particles has advanced significantly over 50 years.
  • Particle therapy shows potential for reduced toxicity and improved efficacy compared to conventional X-ray therapy.
  • It is the most mature technology for clinical translation of ultra-high dose rate (FLASH) radiotherapy.

Purpose of the Study:

  • To highlight the evolution and potential of particle therapy in cancer treatment.
  • To identify key technological innovations required for broader clinical adoption.
  • To emphasize the need for international collaboration in advancing particle therapy.

Main Methods:

  • Review of technological advancements in particle therapy over the past 50 years.
  • Analysis of clinical results supporting the efficacy and reduced toxicity of particle beams.
  • Identification of promising technological solutions for cost reduction, improved conformity, and speed.

Main Results:

  • Particle therapy is a rapidly growing field with increasing clinical centers and supporting evidence.
  • Ultra-high dose rate (FLASH) radiotherapy is a key area for particle technology translation.
  • Technological innovations like compact accelerators, gantryless systems, and AI-driven adaptive therapy are crucial.

Conclusions:

  • Particle therapy offers significant advantages over conventional treatments for select cancer patients.
  • Further technological innovation is essential to make particle therapy more accessible and cost-effective.
  • International collaboration is vital to accelerate the clinical translation of particle therapy research.